Despite its explosive gains over the past few weeks, the marijuana industry, in many ways, is still in its infancy. Medical and recreational cannabis sales are forecast to climb to a monstrous $146.4 billion by the end of 2025, according to…
Author: admin
Better Marijuana Stock: MedMen Enterprises Inc. (MMNFF) vs. CannTrust Holdings Inc. (CNTTF)
Which stock wins in a matchup between a U.S. marijuana retailer and a Canadian cannabis grower? Marijuana stocks aren’t all alike. MedMen Enterprises Inc. (NASDAQOTH:MMNFF) and CannTrust Holdings Inc. (NASDAQOTH:CNTTF) prove the point. Their business models are very different. MedMen is a U.S.-based company, while CannTrust is headquartered…
2 Serious Challenges For This Top Marijuana Stock
Though this pot stock has been unstoppable for years, things may not stay that way for much longer. Big things are happening in the cannabis industry — especially with our neighbor to the north. In 34 days, on Oct. 17, recreational…
2 Small-Cap Marijuana Stocks Poised for Big Gains
Marijuana stocks have easily outpaced the broader markets this year and for good reason. The legal pot market is projected to expand at a compound annual growth rate of 19.75% over the next 13 years, making it one of the…
Which pot stock is a better buy, OrganiGram Holdings Inc (OGRMF) or CannTrust Holdings (CANN)?
Canadian marijuana stocks have been going gangbusters in the past few weeks, thanks to the upcoming legalization of cannabis for recreational purposes in the country on Oct. 17. This key event, after all, has sparked a flurry of partnerships and…
Is it time to sell pot stock Tilray (TLRY)?
Since pricing its shares at $17 on July 18, Tilray’s stock is up over 350%. Throughout the first half of 2018, marijuana stocks turned in a dismal performance. But over the past couple of weeks, they’ve been all the buzz, once…
3 Marijuana Stocks You Can Safely Leave Out of Your Portfolio
These popular pot stocks probably won’t have investors seeing green. In just over two more months, marijuana investors should begin to “see the green.” After years of promises and months of debate, the Cannabis Act, which legalizes recreational marijuana, was…
3 Reasons This Marijuana Stock Could Be Ready to Rebound
There could be a light at the end of the tunnel for Insys Therapeutics. But maybe not. Could the worst be over for Insys Therapeutics (NASDAQ:INSY)? The cannabinoid-focused biotech has been singing the blues for quite a while. Government investigations into its…
The Craziest Marijuana Statistic From July
It was a rough month to be a pot-stock investor. Excitement has been budding for years in the legal cannabis space, and we’ve begun to see that translate into tangible results. In the U.S., Oklahoma recently became the 30th state…
This top-tier pot stock’s Q4 and full-year report is a WARNING to all marijuana investors
In a little over two months, the date Canadian cannabis enthusiasts and investors have long been waiting for will finally arrive. On October 17, recreational marijuana will officially go on sale in our neighbor to the north, following passage of the Cannabis…
